Cell death induced by baicalein in human hepatocellular carcinoma cell lines

Japanese Journal of Cancer Research

Volumn 87, Issue 2, 1996, Pages 170-177

  Matsuzaki, Yuko ^a   Kurokawa, Norie ^a   Terai, Shuji ^a   Matsumura, Yasuhiro ^a   Kobayashi, Nobuyuki ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Baicalein; Cell death; Hepatocellular carcinoma; Sho saiko to (TJ 9)

Indexed keywords

BAICALEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); FLAVONOID; XIAO CHAI HU TANG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 0029933357     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03155.x     Document Type: Article

References (47)

1. Okita, K., Kurokawa, N., Yamasaki, T., Furukawa, T., Li, Q., Murakami, T. and Takahashi, M. The use of Shosaiko-to (TJ-9) for chemoprevention of chemical hepatocarcinogenesis in rats and discussion of its possible pharmacologic action. Transgenica, 1, 39-44 (1994).
2. Tatsuta, M., Iishi, H., Baba, M., Nakaizumi, A. and Uehara, H. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats. Jpn. J. Cancer Res., 82, 987-992 (1991).
3. Shibata, Y., Ohashi, H., Fujii, K., Mizoguchi, Y. and Morisawa, S. Effects of syô-saiko-tô on antitumor activities. J. Med. Pharm. Soc., 3, 189-193 (1986).
4. Mizoguchi, A. Inhibitory effect of the aqueous soluble fraction of sho-saiko-to on the growth of various human cancer cell lines established from the hepatobiliary system. J. Med. Pharm. Soc., 9, 110-117 (1992).
5. Kobayashi, K., Nakao, M., Harihara, S., Marumo, T., Kobayashi, Y. and Monna, T. Controlled prospective evaluation of sho-saiko-to in prevention of hepatocellular carcinoma in patients with cirrhosis of the liver. J. Med. Pharm. Soc., 6, 40-44 (1989).
6. Ito, H. and Shimura, K. Effects of a blended Chinese medicine, xiao-chai-hu-tang, on Lewis lung carcinoma growth and inhibition of lung metastasis, with special reference to macrophage activation. Jpn. J. Pharmacol., 41, 307-314 (1986).
7. Kitamura, M., Mizoguchi, Y., Yamamoto, S., Shibata, Y. and Morisawa, S. Antitumor activities of the syô-saiko-tô-activated macrophages in mice. J. Med. Pharm. Soc., 2, 32-38 (1985).
8. Mizoguchi, Y., Sakagami, Y., Miyazima, K. and Yamamoto, Y. The effects of xiao-chai-hu-tang (syosaiko-to) on lymphokine-activated killer (LAK) cell activity. Allergy, 35, 1119-1121 (1986).
9. Mizoguchi, Y., Fujinobu, Y., Kobayashi, K., Yamamoto, S. and Morisawa, S. The effects of xiao-chai-hu-tang (syô-saiko-tô) on natural killer (NK) cell activity. J. Med. Pharm. Soc., 3, 184-188 (1986).
10. 1 phase. Cancer Res., 54, 448-454 (1994).
11. Okita, K., Li, Q., Murakami, T. and Takahashi, M. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur. J. Cancer Prev., 2, 169-176 (1993).
12. Li, Q., Okita, K., Murakami, T. and Takahashi, M. Inhibitory effect of baicalein on the growth of cultured hepatoma cells (HuH-7). Biotherapy, 4, 1664-1670 (1990).
13. Sasaki, K., Murakami, T., Oga, A., Takahashi, M. and Okita, K. Effects of glycyrrhizin on cell proliferation and α-fetoprotein production of human hepatoma cell line HuH-7. Biotherapy, 3, 1515-1518 (1989).
14. Tricoli, J. V., Sahai, B. M., McCormick, P. J., Jarlinski, S. J., Bertram, J. S. and Kowalski, D. DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblast (C3H 10T 1/2) cells. Exp. Cell Res., 158, 1-14 (1985).
15. Austin, C. A., Patel, S., Ono, K., Nakane, H. and Fisher, L. M. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem. J., 282, 883-889 (1992).
16. Markovits, J., Linassier, C., Fosse, P., Couprie, J., Piere, J., Jacquemin-Sablon, A., Saucier, J. M., Le Pecq, J. B. and Larsen, A. K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 49, 5111-5117 (1989).
17. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49, 5870-5878 (1989).
18. Walker, P. R., Smith, C., Youdale, T., Leblanc, J., Whitfield, J. F. and Sikorska, M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51, 1078-1085 (1991).
19. Ling, Y. H., Priebe, W. and Perez, S. R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res., 53, 1845-1852 (1993).
20. Stevnsner, T. and Bohr, V. A. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair. Carcinogenesis, 14, 1841-1850 (1993).
21. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T. and Sato, J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res., 42, 3858-3863 (1982).
22. Murakami, T. Establishment and characterization of human hepatoma cell line (KIM-1). Acta Hepatol. Jpn., 25, 532-539 (1984).
23. Doi, I., Namba, M. and Sato, J. Establishment and some biological characteristics of human hepatoma cell lines. Gann, 66, 385-392 (1975).
24. Hilwig, I. and Gropp, A. Staining of consecutive heterochromatin in mammalian chromosomes with a new fluorochrome. Exp. Cell Res., 75, 122-126 (1972).
25. Labarca, C. and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem., 102, 344-352 (1980).
26. Smith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J. and Owen, J. J. T. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature, 337, 181-184 (1989).
27. Cohen, J. K. and Duke, R, C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol., 132, 38-42 (1984).
28. Marini, J. C., Miller, K. G. and Englund, P. T. Decatenation of kinetoplast DNA by topoisomerases. J. Biol. Chem., 255, 4976-4979 (1980).
29. Muller, M. T., Spitzner, J. R., DiDonato, J. A., Mehta, V. B., Tsutsui, K. and Tsutsui, K. Single-strand DNA cleavages by eukaryotic topoisomerase II. Biochemistry, 27, 8369-8379 (1988).
30. Yonehara, S., Ishii, A. and Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169, 1747-1756 (1989).
31. Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Moller, P., Falk, W., Debatin, K.-M. and Krammer, P. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305 (1989).
32. Owen-Schaub, L. B., Radinsky, R., Kruzel, E., Berry, K. and Yonehara, S. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54, 1580-1586 (1994).
33. Kerr, J. F. R., Wyllie, A. H. and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239-257 (1972).
34. Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y. and Jacobson, M. D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science, 262, 695-700 (1993).
35. Laurent-Crawford, A. G., Krust, B., Muller, S., Rivière, Y., Rey-Cuillé, M.-A., Béchet, J.-M., Montagnier, L. and Hovanessian, A. G. The cytopathic effect of HIV is associated with apoptosis. Virology, 85, 829-839 (1991).
36. William, G. T. Programmed cell death: apoptosis and oncogenesis. Cell, 65, 1097-1098 (1991).
37. Oren, M. The involvement of oncogenes and tumor suppressor gene in the control of apoptosis. Cancer Metastasis Rev., 11, 141-147 (1992).
38. Bursch, W., Lauer, B., Timmermann-Trosiener, T., Barthel, G., Schuppler, J. and Schulte-Hermann, R. Controlled cell death (apoptosis) of normal and putative pre-neoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458 (1984).
39. Hickman, J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11, 121 139 (1992).
40. Morimoto, H., Yonehara, S. and Bonavida, B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res., 53, 2591-2596 (1993).
41. 1. Cancer Res., 52, 385-388 (1992).
42. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849 (1993).
43. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L. and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852 (1993).
44. Kamesaki, S., Kamesaki, H., Jorgensen, T. J., Tanizawa, A., Pommier, Y. and Cossman, J. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res., 53, 4251-4256 (1993).
45. Terai, S., Matsuzaki, Y., Masuhara, M., Kondou, S., Yasunaga, M. and Okita, K. High MDM2 mRNA expression in hepatoblastoma cell-lines. Int. Hepatol. Commun., 3, 330-336 (1995).
46. Lennon, S. V., Martin, S. J. and Cotter, T. G. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Proliferation, 24, 203-214 (1991).
47. Fernandes, R. S. and Cotter, T. G. Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death. Biochem. Pharmacol., 48, 675-681 (1994).